.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Healthtrust
Cantor Fitzgerald
Johnson and Johnson
Cipla
Harvard Business School
Novartis
Colorcon
Julphar
Teva

Generated: December 12, 2017

DrugPatentWatch Database Preview

Aurobindo Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has three hundred and two approved drugs.

There are thirty-five tentative approvals on AUROBINDO drugs.

Summary for Aurobindo

US Patents:0
Tradenames:231
Ingredients:207
NDAs:302
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma LtdQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL202725-001Apr 29, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdNYLIA 7/7/7ethinyl estradiol; norethindroneTABLET;ORAL-28207054-001Oct 21, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdDIVALPROEX SODIUMdivalproex sodiumTABLET, DELAYED RELEASE;ORAL090554-001Apr 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdVALSARTANvalsartanTABLET;ORAL202223-002Jan 5, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdVANCOMYCIN HYDROCHLORIDEvancomycin hydrochlorideINJECTABLE;INJECTION205780-001Mar 31, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdONDANSETRON HYDROCHLORIDEondansetron hydrochlorideINJECTABLE;INJECTION202599-001Dec 21, 2012APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdDALFAMPRIDINEdalfampridineTABLET, EXTENDED RELEASE;ORAL206811-001Jan 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo PharmaLEVETIRACETAMlevetiracetamTABLET;ORAL078993-004Jan 15, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdPITAVASTATIN CALCIUMpitavastatin calciumTABLET;ORAL206015-002Dec 20, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Aurobindo Pharma LtdQUETIAPINE FUMARATEquetiapine fumarateTABLET;ORAL091388-002Mar 27, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for AUROBINDO drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazoleDelayed-release Tablets20 mgOMEPRAZOLE6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Dow
Federal Trade Commission
Covington
Johnson and Johnson
Boehringer Ingelheim
Baxter
Moodys
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot